UK markets open in 5 hours 54 minutes

Innovent Biologics, Inc. (1801.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
38.200-1.950 (-4.86%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
6,206,070
6,206,070
4,556,380
4,269,729
3,843,819
Cost of revenue
1,136,266
1,136,266
930,990
505,337
387,761
Gross profit
5,069,804
5,069,804
3,625,390
3,764,392
3,456,058
Operating expenses
Research development
2,227,556
2,227,556
2,871,220
2,322,513
1,851,453
Selling general and administrative
3,850,971
3,850,971
3,426,253
3,426,152
1,777,733
Total operating expenses
5,979,014
5,979,014
6,207,275
5,703,539
3,498,501
Operating income or loss
-909,210
-909,210
-2,581,885
-1,939,147
-42,443
Interest expense
98,624
98,624
101,698
62,464
68,350
Income before tax
-1,144,411
-1,144,411
-2,170,469
-2,641,717
-858,713
Income tax expense
-116,498
-116,498
8,801
87,038
139,708
Income from continuing operations
-1,027,913
-1,027,913
-2,179,270
-2,728,755
-998,421
Net income
-1,027,913
-1,027,913
-2,179,270
-2,728,755
-998,421
Net income available to common shareholders
-1,027,913
-1,027,913
-2,179,270
-2,728,755
-998,421
Basic EPS
-0.90
-0.66
-1.46
-1.88
-0.74
Diluted EPS
-0.90
-0.66
-1.46
-1.88
-0.74
Basic average shares
1,525,269
1,559,637
1,490,123
1,455,606
1,357,012
Diluted average shares
1,525,269
1,559,637
1,490,123
1,455,606
1,357,012